Valuation Metrics Reflect Enhanced Price Appeal
The latest data reveals Mangalam Organics’ P/E ratio stands at 12.44, a figure that is considerably lower than many of its peers in the commodity chemicals industry. For context, competitors such as Sanstar and Stallion India trade at P/E multiples of 78.39 and 40.93 respectively, underscoring Mangalam’s relative valuation discount. This lower P/E ratio suggests the market currently prices Mangalam’s earnings more conservatively, potentially offering a margin of safety for value-oriented investors.
Complementing the P/E ratio, the company’s price-to-book value is reported at 1.11, indicating the stock is trading close to its book value. This is a critical metric for commodity chemical firms, where asset backing often provides a tangible floor to valuations. The P/BV ratio’s proximity to unity further supports the notion that Mangalam Organics is priced attractively relative to its net asset base.
Enterprise Value Multiples and Profitability Ratios
Examining enterprise value (EV) multiples, Mangalam Organics posts an EV to EBIT of 18.13 and an EV to EBITDA of 11.38. While these multiples are higher than some peers, they remain reasonable given the company’s operational scale and earnings quality. The EV to capital employed ratio at 1.05 and EV to sales at 1.12 also suggest the stock is not overvalued on a capital or revenue basis.
Profitability metrics, however, paint a more cautious picture. The company’s return on capital employed (ROCE) is 5.37%, and return on equity (ROE) stands at 8.72%. These returns are modest and indicate room for operational improvement. Investors should weigh these profitability levels against the valuation discount to assess the stock’s risk-reward profile effectively.
Comparative Industry Valuation Landscape
When benchmarked against its industry peers, Mangalam Organics’ valuation stands out as very attractive. For instance, Titan Biotech, another commodity chemicals firm, trades at a P/E of 39.03 and EV to EBITDA of 31.88, reflecting a premium valuation. Similarly, companies like Platinum Industrials and Gem Aromatics hold fair to attractive valuations but still trade at higher multiples than Mangalam.
Interestingly, some peers such as I G Petrochems and TGV Sraac are also rated very attractive, with TGV Sraac’s P/E at 7.26 and EV to EBITDA at 3.43, indicating even deeper discounts. This suggests that while Mangalam Organics is attractively priced, investors have alternative options within the sector that may offer different risk-return dynamics.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Stock Price Performance and Market Context
Mangalam Organics’ current share price is ₹401.10, slightly up by 0.92% from the previous close of ₹397.45. The stock has experienced a 52-week high of ₹654.05 and a low of ₹339.00, indicating a wide trading range over the past year. Despite this volatility, the stock’s recent price movement suggests some stability near the lower end of its range, which may be attractive to value investors.
However, the stock’s returns relative to the benchmark Sensex reveal underperformance over multiple time horizons. Year-to-date, Mangalam Organics has declined by 18.64%, compared to the Sensex’s 6.11% gain. Over one year, the stock is down 3.35%, while the Sensex has appreciated 8.53%. Even over five years, Mangalam has delivered a negative return of 25.21%, contrasting sharply with the Sensex’s robust 58.74% gain.
On a longer-term basis, the stock’s 10-year return is an impressive 1925.76%, vastly outperforming the Sensex’s 224.65%. This suggests that while recent performance has been lacklustre, Mangalam Organics has historically rewarded patient investors handsomely.
Mojo Score and Rating Revision
MarketsMOJO’s proprietary Mojo Score for Mangalam Organics currently stands at 46.0, with a Mojo Grade of Sell. This represents a downgrade from the previous Hold rating as of 10 Dec 2025. The downgrade reflects concerns over the company’s operational metrics and recent price underperformance despite the improved valuation multiples.
The market capitalisation grade is rated 4, indicating a micro-cap status, which often entails higher volatility and risk. Investors should consider this alongside the valuation appeal and the company’s modest profitability ratios when making investment decisions.
Investment Implications and Outlook
The shift in Mangalam Organics’ valuation grade from attractive to very attractive is a noteworthy development for investors seeking value opportunities in the commodity chemicals sector. The company’s low P/E and P/BV ratios relative to peers provide a compelling entry point, especially given the subdued market sentiment and recent price weakness.
Nevertheless, the modest returns on capital and equity, combined with the stock’s underperformance against the Sensex in the short to medium term, warrant caution. Investors should balance the valuation appeal against operational challenges and sector dynamics before committing capital.
Given the downgrade to a Sell rating by MarketsMOJO, it is clear that while the stock is attractively priced, it may not yet be ready for a sustained recovery. Monitoring improvements in profitability and market conditions will be crucial for reassessing the stock’s investment merit.
Why settle for Mangalam Organics Ltd? SwitchER evaluates this Commodity Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Conclusion: Valuation Opportunity Amid Operational Headwinds
Mangalam Organics Ltd’s recent valuation upgrade to very attractive highlights a significant shift in market perception, primarily driven by its low P/E and P/BV ratios compared to peers. This repositioning offers a potential value entry point for investors willing to look beyond near-term operational challenges and sector headwinds.
However, the downgrade in the Mojo Grade to Sell and the company’s modest profitability metrics suggest that caution remains warranted. Investors should closely monitor the company’s financial performance and broader market trends before increasing exposure.
Ultimately, Mangalam Organics presents a nuanced investment case: a stock with compelling valuation metrics but requiring operational improvements and market confidence to unlock its full potential.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
